These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24894520)

  • 21. Development of an in vitro drug-drug interaction assay to simultaneously monitor five cytochrome P450 isoforms and performance assessment using drug library compounds.
    Zientek M; Miller H; Smith D; Dunklee MB; Heinle L; Thurston A; Lee C; Hyland R; Fahmi O; Burdette D
    J Pharmacol Toxicol Methods; 2008; 58(3):206-14. PubMed ID: 18634893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A method for the simultaneous evaluation of the activities of seven major human drug-metabolizing cytochrome P450s using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectrometry.
    Dierks EA; Stams KR; Lim HK; Cornelius G; Zhang H; Ball SE
    Drug Metab Dispos; 2001 Jan; 29(1):23-9. PubMed ID: 11124225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-Throughput Cytochrome P450 Cocktail Inhibition Assay for Assessing Drug-Drug and Drug-Botanical Interactions.
    Li G; Huang K; Nikolic D; van Breemen RB
    Drug Metab Dispos; 2015 Nov; 43(11):1670-8. PubMed ID: 26285764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro oxidative metabolism of cajaninstilbene Acid by human liver microsomes and hepatocytes: involvement of cytochrome p450 reaction phenotyping, inhibition, and induction studies.
    Hua X; Peng X; Tan S; Li C; Wang W; Luo M; Fu Y; Zu Y; Smyth H
    J Agric Food Chem; 2014 Oct; 62(43):10604-14. PubMed ID: 25272989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of the relative activity factor approach in scaling from heterologously expressed cytochromes p450 to human liver microsomes: studies on amitriptyline as a model substrate.
    Venkatakrishnan K; von Moltke LL; Greenblatt DJ
    J Pharmacol Exp Ther; 2001 Apr; 297(1):326-37. PubMed ID: 11259560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A liquid chromatography-tandem mass spectrometry analysis of nine cytochrome P450 probe drugs and their corresponding metabolites in human serum and urine.
    Puris E; Pasanen M; Gynther M; Häkkinen MR; Pihlajamäki J; Keränen T; Honkakoski P; Raunio H; Petsalo A
    Anal Bioanal Chem; 2017 Jan; 409(1):251-268. PubMed ID: 27734142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A high-throughput inhibition screening of major human cytochrome P450 enzymes using an in vitro cocktail and liquid chromatography-tandem mass spectrometry.
    Qin CZ; Ren X; Tan ZR; Chen Y; Yin JY; Yu J; Qu J; Zhou HH; Liu ZQ
    Biomed Chromatogr; 2014 Feb; 28(2):197-203. PubMed ID: 23946123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative metabolism of tussilagone in rat and human liver microsomes using ultra-high-performance liquid chromatography coupled with high-resolution LTQ-Orbitrap mass spectrometry.
    Zhang XS; Ren W; Bian BL; Zhao HY; Wang S
    Rapid Commun Mass Spectrom; 2015 Sep; 29(18):1641-50. PubMed ID: 26467116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human cytochrome P4502B6: interindividual hepatic expression, substrate specificity, and role in procarcinogen activation.
    Code EL; Crespi CL; Penman BW; Gonzalez FJ; Chang TK; Waxman DJ
    Drug Metab Dispos; 1997 Aug; 25(8):985-93. PubMed ID: 9280407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective inhibition of the cytochrome P450 isoform by hyperoside and its potent inhibition of CYP2D6.
    Song M; Hong M; Lee MY; Jee JG; Lee YM; Bae JS; Jeong TC; Lee S
    Food Chem Toxicol; 2013 Sep; 59():549-53. PubMed ID: 23835282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liquid chromatography/tandem mass spectrometry method for simultaneous evaluation of activities of five cytochrome P450s using a five-drug cocktail and application to cytochrome P450 phenotyping studies in rats.
    Zhang S; Song N; Li Q; Fan H; Liu C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Aug; 871(1):78-89. PubMed ID: 18614408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes.
    Ono S; Hatanaka T; Hotta H; Satoh T; Gonzalez FJ; Tsutsui M
    Xenobiotica; 1996 Jul; 26(7):681-93. PubMed ID: 8819299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of stable isotope labeled probes to facilitate liquid chromatography/mass spectrometry based high-throughput screening of time-dependent CYP inhibitors.
    Dasgupta M; Tang W; Caldwell GW; Yan Z
    Rapid Commun Mass Spectrom; 2010 Aug; 24(15):2177-85. PubMed ID: 20583325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cocktail-substrate approach-based high-throughput assay for evaluation of direct and time-dependent inhibition of multiple cytochrome P450 isoforms.
    Kozakai K; Yamada Y; Oshikata M; Kawase T; Suzuki E; Haramaki Y; Taniguchi H
    Drug Metab Pharmacokinet; 2014; 29(2):198-207. PubMed ID: 24172718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-throughput cytochrome p450 inhibition assays by ultrafast gradient liquid chromatography with tandem mass spectrometry using monolithic columns.
    Peng SX; Barbone AG; Ritchie DM
    Rapid Commun Mass Spectrom; 2003; 17(6):509-18. PubMed ID: 12621611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic profiling of five flavonoids from Dragon's Blood in human liver microsomes using high-performance liquid chromatography coupled with high resolution mass spectrometry.
    Li Y; Zhang Y; Wang R; Wei L; Deng Y; Ren W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 May; 1052():91-102. PubMed ID: 28376352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of human cytochrome P450 enzymes involved in the metabolism of cyamemazine.
    Arbus C; Benyamina A; Llorca PM; Baylé F; Bromet N; Massiere F; Garay RP; Hameg A
    Eur J Pharm Sci; 2007 Dec; 32(4-5):357-66. PubMed ID: 17951033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of the human liver cytochrome P450 isoenzymes responsible for the 5-methylhydroxylation of the novel anti-fibrotic drug AKF-PD.
    He X; Luo X; Liu Z; Hu G; Cheng Z
    Xenobiotica; 2011 Oct; 41(10):844-50. PubMed ID: 21679010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biosynthesis of all-trans-retinoic acid from all-trans-retinol: catalysis of all-trans-retinol oxidation by human P-450 cytochromes.
    Chen H; Howald WN; Juchau MR
    Drug Metab Dispos; 2000 Mar; 28(3):315-22. PubMed ID: 10681376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple P450 substrates in a single run: rapid and comprehensive in vitro interaction assay.
    Turpeinen M; Uusitalo J; Jalonen J; Pelkonen O
    Eur J Pharm Sci; 2005 Jan; 24(1):123-32. PubMed ID: 15626586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.